{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:01:33Z","timestamp":1789657293003,"version":"4.0.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"clinical and translational science center at Weill cornell","award":["1-UL1-TR002384-01"],"award-info":[{"award-number":["1-UL1-TR002384-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11060-021-03910-8","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T19:03:57Z","timestamp":1642446237000},"page":"431-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-2400","authenticated-orcid":false,"given":"Umberto","family":"Tosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omri","family":"Maayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjile","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel E. Tusa","family":"Lavieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio W.","family":"Guadix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio P.","family":"DeRosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Christos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Pannullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip E.","family":"Stieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Brandmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P. S.","family":"Knisely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Ramakrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"key":"3910_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R (2005) Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 26:93\u201397. https:\/\/doi.org\/10.1097\/00129492-200501000-00016","journal-title":"Otol Neurotol"},{"key":"3910_CR2","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/s0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR (2009) Neurofibromatosis type 2. Lancet 373:1974\u20131986. https:\/\/doi.org\/10.1016\/s0140-6736(09)60259-2","journal-title":"Lancet"},{"key":"3910_CR3","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.ajo.2005.12.042","volume":"141","author":"MM Bosch","year":"2006","unstructured":"Bosch MM, Boltshauser E, Harpes P, Landau K (2006) Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 141:1068\u20131077. https:\/\/doi.org\/10.1016\/j.ajo.2005.12.042","journal-title":"Am J Ophthalmol"},{"key":"3910_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00439-018-1909-9","volume":"137","author":"H Kehrer-Sawatzki","year":"2018","unstructured":"Kehrer-Sawatzki H, Kluwe L, Friedrich RE, Summerer A, Schafer E, Wahllander U, Matthies C, Gugel I, Farschtschi S, Hagel C, Cooper DN, Mautner VF (2018) Phenotypic and genotypic overlap between mosaic NF2 and schwannomatosis in patients with multiple non-intradermal schwannomas. Hum Genet 137:543\u2013552. https:\/\/doi.org\/10.1007\/s00439-018-1909-9","journal-title":"Hum Genet"},{"key":"3910_CR5","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/archderm.1997.03890480059008","volume":"133","author":"VF Mautner","year":"1997","unstructured":"Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J (1997) Skin abnormalities in neurofibromatosis 2. Arch Dermatol 133:1539\u20131543","journal-title":"Arch Dermatol"},{"key":"3910_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3171\/jns.2003.99.3.0480","volume":"99","author":"G Otsuka","year":"2003","unstructured":"Otsuka G, Saito K, Nagatani T, Yoshida J (2003) Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2. J Neurosurg 99:480\u2013483. https:\/\/doi.org\/10.3171\/jns.2003.99.3.0480","journal-title":"J Neurosurg"},{"key":"3910_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1148\/radiology.218.2.r01fe40434","volume":"218","author":"NJ Patronas","year":"2001","unstructured":"Patronas NJ, Courcoutsakis N, Bromley CM, Katzman GL, MacCollin M, Parry DM (2001) Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype. Radiology 218:434\u2013442. https:\/\/doi.org\/10.1148\/radiology.218.2.r01fe40434","journal-title":"Radiology"},{"key":"3910_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035711","volume":"7","author":"SR Plotkin","year":"2012","unstructured":"Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF (2012) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS ONE 7:e35711. https:\/\/doi.org\/10.1371\/journal.pone.0035711","journal-title":"PLoS ONE"},{"key":"3910_CR9","first-page":"603","volume":"84","author":"DG Evans","year":"1992","unstructured":"Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603\u2013618","journal-title":"Q J Med"},{"key":"3910_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-2005-837581","volume":"36","author":"M Ruggieri","year":"2005","unstructured":"Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, Platania N, Gabriele AL, Albanese V, Pavone L (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 36:21\u201334. https:\/\/doi.org\/10.1055\/s-2005-837581","journal-title":"Neuropediatrics"},{"key":"3910_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/mao.0000000000001690","volume":"39","author":"AT deTorres","year":"2018","unstructured":"deTorres AT, Brewer CC, Zalewski CK, King KA, Walker R, Scott GC, Asthagiri AR, Chittiboina P, Kim HJ (2018) Audiologic natural history of small volume cochleovestibular schwannomas in neurofibromatosis type 2. Otol Neurotol 39:357\u2013364. https:\/\/doi.org\/10.1097\/mao.0000000000001690","journal-title":"Otol Neurotol"},{"key":"3910_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1136\/jmg.2005.031302","volume":"42","author":"ME Baser","year":"2005","unstructured":"Baser ME, Mautner VF, Parry DM, Evans DG (2005) Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2. J Med Genet 42:903\u2013906. https:\/\/doi.org\/10.1136\/jmg.2005.031302","journal-title":"J Med Genet"},{"key":"3910_CR13","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1097\/mao.0000000000002557","volume":"41","author":"EM Dowling","year":"2020","unstructured":"Dowling EM, Marinelli JP, Lohse CM, Carlson ML (2020) Contextualizing the modern epidemiology of neurofibromatosis type 2 in an era of heightened detection of sporadic vestibular schwannoma. Otol Neurotol 41:e501\u2013e506. https:\/\/doi.org\/10.1097\/mao.0000000000002557","journal-title":"Otol Neurotol"},{"key":"3910_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28228","volume":"67","author":"S Renzi","year":"2020","unstructured":"Renzi S, Michaeli O, Salvador H, Alderete D, Ponce NF, Zapotocky M, Hansford JR, Malalasekera VS, Toledano H, Maguire B, Bouffet E, Ramaswamy V, Baroni LV (2020) Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence. Pediatr Blood Cancer 67:e28228. https:\/\/doi.org\/10.1002\/pbc.28228","journal-title":"Pediatr Blood Cancer"},{"key":"3910_CR15","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1038\/s41598-020-60156-6","volume":"10","author":"JE Sagers","year":"2020","unstructured":"Sagers JE, Beauchamp RL, Zhang Y, Vasilijic S, Wu L, DeSouza P, Seist R, Zhou W, Xu L, Ramesh V, Stankovic KM (2020) Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. Sci Rep 10:4211. https:\/\/doi.org\/10.1038\/s41598-020-60156-6","journal-title":"Sci Rep"},{"key":"3910_CR16","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/mao.0000000000002316","volume":"40","author":"TA Janz","year":"2019","unstructured":"Janz TA, Camilon PR, Cheung AY, Nguyen SA, Meyer TA, McRackan TR, Lambert PR (2019) Characteristics and outcomes of pediatric vestibular schwannomas. Otol Neurotol 40:1047\u20131053. https:\/\/doi.org\/10.1097\/mao.0000000000002316","journal-title":"Otol Neurotol"},{"key":"3910_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00405-019-05741-w","volume":"277","author":"N West","year":"2020","unstructured":"West N, Sass H, Caye-Thomasen P (2020) Sporadic and NF2-associated vestibular schwannoma surgery and simultaneous cochlear implantation: a comparative systematic review. Eur Arch Otorhinolaryngol 277:333\u2013342. https:\/\/doi.org\/10.1007\/s00405-019-05741-w","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3910_CR18","first-page":"91","volume":"6","author":"J Leon","year":"2019","unstructured":"Leon J, Lehrer EJ, Peterson J, Vallow L, Ruiz-Garcia H, Hadley A, Herchko S, Lundy L, Chaichana K, Vibhute P, Sheehan JP, Trifiletti DM (2019) Observation or stereotactic radiosurgery for newly diagnosed vestibular schwannomas: a systematic review and meta-analysis. J Radiosurg SBRT 6:91\u2013100","journal-title":"J Radiosurg SBRT"},{"key":"3910_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJMoa0902579","volume":"361","author":"SR Plotkin","year":"2009","unstructured":"Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E (2009) Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 361:358\u2013367. https:\/\/doi.org\/10.1056\/NEJMoa0902579","journal-title":"N Engl J Med"},{"key":"3910_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.neuchi.2015.03.012","volume":"64","author":"M Peyre","year":"2018","unstructured":"Peyre M, Bernardeschi D, Sterkers O, Kalamarides M (2018) Natural history of vestibular schwannomas and hearing loss in NF2 patients. Neurochirurgie 64:342\u2013347. https:\/\/doi.org\/10.1016\/j.neuchi.2015.03.012","journal-title":"Neurochirurgie"},{"key":"3910_CR21","unstructured":"(2020) Auditory brainstem implantation for adults with neurofibromatosis 2 or severe inner ear abnormalities: A health technology assessment. Ont Health Technol Assess Ser 20: 1\u201385"},{"key":"3910_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000485526","volume":"81","author":"HJD North","year":"2018","unstructured":"North HJD, Lloyd SKW (2018) Hearing rehabilitation in neurofibromatosis type 2. Adv Otorhinolaryngol 81:93\u2013104. https:\/\/doi.org\/10.1159\/000485526","journal-title":"Adv Otorhinolaryngol"},{"key":"3910_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.neuchi.2018.09.003","volume":"64","author":"H Jia","year":"2018","unstructured":"Jia H, El Sayed MME, Smail M, Mosnier I, Wu H, Sterkers O, Kalamarides M, Bernardeschi D (2018) Neurofibromatosis type 2: hearing preservation and rehabilitation. Neurochirurgie 64:348\u2013354. https:\/\/doi.org\/10.1016\/j.neuchi.2018.09.003","journal-title":"Neurochirurgie"},{"key":"3910_CR24","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/coa.12882","volume":"42","author":"SKW Lloyd","year":"2017","unstructured":"Lloyd SKW, King AT, Rutherford SA, Hammerbeck-Ward CL, Freeman SRM, Mawman DJ, O\u2019Driscoll M, Evans DG (2017) Hearing optimisation in neurofibromatosis type 2: a systematic review. Clin Otolaryngol 42:1329\u20131337. https:\/\/doi.org\/10.1111\/coa.12882","journal-title":"Clin Otolaryngol"},{"key":"3910_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-020-01279-2","author":"EJ Buss","year":"2020","unstructured":"Buss EJ, Wang TJC, Sisti MB (2020) Stereotactic radiosurgery for management of vestibular schwannoma: a short review. Neurosurg Rev. https:\/\/doi.org\/10.1007\/s10143-020-01279-2","journal-title":"Neurosurg Rev"},{"key":"3910_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0194599817695805","volume":"157","author":"H Mahboubi","year":"2017","unstructured":"Mahboubi H, Sahyouni R, Moshtaghi O, Tadokoro K, Ghavami Y, Ziai K, Lin HW, Djalilian HR (2017) CyberKnife for treatment of vestibular schwannoma: a meta-analysis. Otolaryngol Head Neck Surg 157:7\u201315. https:\/\/doi.org\/10.1177\/0194599817695805","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3910_CR27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00701-017-3164-6","volume":"159","author":"O Persson","year":"2017","unstructured":"Persson O, Bartek J Jr, Shalom NB, Wangerid T, Jakola AS, Forander P (2017) Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review. Acta Neurochir 159:1013\u20131021. https:\/\/doi.org\/10.1007\/s00701-017-3164-6","journal-title":"Acta Neurochir"},{"issue":"Suppl","key":"3910_CR28","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.canrad.2012.01.006","volume":"16","author":"J Regis","year":"2012","unstructured":"Regis J, Carron R, Moucharrafien S, Delsantin C, Porcheron D, Thomassin JM, Murracciole X, Roche PH (2012) Role of radiosurgery and stereotactic radiotherapy in the management of vestibular schwannomas. Cancer Radiother 16(Suppl):S70-78. https:\/\/doi.org\/10.1016\/j.canrad.2012.01.006","journal-title":"Cancer Radiother"},{"key":"3910_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.otc.2005.03.018","volume":"38","author":"PA Wackym","year":"2005","unstructured":"Wackym PA (2005) Stereotactic radiosurgery, microsurgery, and expectant management of acoustic neuroma: basis for informed consent. Otolaryngol Clin North Am 38:653\u2013670. https:\/\/doi.org\/10.1016\/j.otc.2005.03.018","journal-title":"Otolaryngol Clin North Am"},{"key":"3910_CR30","doi-asserted-by":"crossref","unstructured":"Tosi U, Guadix S, An A, Wright D, Christos PJ, Pannullo S, Brandmaier A, Knisely JPS, Stieg PE, Ramakrishna R (2021) Efficacy and comorbidities of hypofractionated and single dose radiosurgery for vestibular schwannomas: a systematic review and meta-analysis. Neuro-Oncol Pract. Online before print","DOI":"10.1093\/nop\/npab009"},{"key":"3910_CR31","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.4103\/0028-3886.271243","volume":"67","author":"BK Misra","year":"2019","unstructured":"Misra BK, Churi ON (2019) Microsurgery of vestibular schwannoma post-radiosurgery. Neurol India 67:1274\u20131278. https:\/\/doi.org\/10.4103\/0028-3886.271243","journal-title":"Neurol India"},{"key":"3910_CR32","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.4103\/0028-3886.271286","volume":"67","author":"M Singh","year":"2019","unstructured":"Singh M (2019) Surgery for vestibular schwannoma following stereotactic radiosurgery. Neurol India 67:1279. https:\/\/doi.org\/10.4103\/0028-3886.271286","journal-title":"Neurol India"},{"key":"3910_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1055\/s-0039-1679898","volume":"81","author":"BA Strickland","year":"2020","unstructured":"Strickland BA, Ravina K, Rennert RC, Jackanich A, Aaron K, Bakhsheshian J, Russin JJ, Friedman RA, Giannotta SL (2020) Intentional subtotal resection of vestibular schwannoma: a reexamination. J Neurol Surg B Skull Base 81:136\u2013141. https:\/\/doi.org\/10.1055\/s-0039-1679898","journal-title":"J Neurol Surg B Skull Base"},{"key":"3910_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-019-01143-y","author":"L Troude","year":"2019","unstructured":"Troude L, Boucekine M, Montava M, Balossier A, Lavieille JP, Regis J, Roche PH (2019) Does NF2 status impact the results of combined surgery and adjunctive gamma knife surgery for large vestibular schwannomas? Neurosurg Rev. https:\/\/doi.org\/10.1007\/s10143-019-01143-y","journal-title":"Neurosurg Rev"},{"key":"3910_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101498","author":"Y Shinya","year":"2019","unstructured":"Shinya Y, Hasegawa H, Shin M, Sugiyama T, Kawashima M, Takahashi W, Iwasaki S, Kashio A, Nakatomi H, Saito N (2019) Long-term outcomes of stereotactic radiosurgery for vestibular schwannoma associated with neurofibromatosis type 2 in comparison to sporadic schwannoma. Cancers. https:\/\/doi.org\/10.3390\/cancers11101498","journal-title":"Cancers"},{"key":"3910_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s1470-2045(18)30659-4","volume":"20","author":"A Wolf","year":"2019","unstructured":"Wolf A, Naylor K, Tam M, Habibi A, Novotny J, Li\u0161\u010d\u00e1k R, Martinez-Moreno N, Martinez-Alvarez R, Sisterson N, Golfinos JG, Silverman J, Kano H, Sheehan J, Lunsford LD, Kondziolka D (2019) Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study. Lancet Oncol 20:159\u2013164. https:\/\/doi.org\/10.1016\/s1470-2045(18)30659-4","journal-title":"Lancet Oncol"},{"key":"3910_CR37","doi-asserted-by":"publisher","first-page":"e929","DOI":"10.1016\/j.wneu.2019.01.211","volume":"125","author":"F Gao","year":"2019","unstructured":"Gao F, Li M, Wang Z, Shi L, Lou L, Zhou J (2019) Efficacy and safety of gamma knife radiosurgery for meningiomas in patients with neurofibromatosis type 2: a long-term follow-up single-center study. World Neurosurg 125:e929\u2013e936. https:\/\/doi.org\/10.1016\/j.wneu.2019.01.211","journal-title":"World Neurosurg"},{"key":"3910_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41467-017-00174-7","volume":"8","author":"S Agnihotri","year":"2017","unstructured":"Agnihotri S, Suppiah S, Tonge PD, Jalali S, Danesh A, Bruce JP, Mamatjan Y, Klironomos G, Gonen L, Au K, Mansouri S, Karimi S, Sahm F, von Deimling A, Taylor MD, Laperriere NJ, Pugh TJ, Aldape KD, Zadeh G (2017) Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas. Nat Commun 8:186. https:\/\/doi.org\/10.1038\/s41467-017-00174-7","journal-title":"Nat Commun"},{"key":"3910_CR39","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijrobp.2019.02.057","volume":"104","author":"JL Co","year":"2019","unstructured":"Co JL, Swain M, Murray LJ, Ahmed S, Laperriere NJ, Tsang DS, Yu E, Pintilie M, Weiss J, Hodgson DC (2019) Meningioma screening with MRI in childhood leukemia survivors treated with cranial radiation. Int J Radiat Oncol Biol Phys 104:640\u2013643. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.02.057","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3910_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jocn.2016.02.002","volume":"30","author":"PF Morgenstern","year":"2016","unstructured":"Morgenstern PF, Shah K, Dunkel IJ, Reiner AS, Khakoo Y, Rosenblum MK, Gutin P (2016) Meningioma after radiotherapy for malignancy. J Clin Neurosci 30:93\u201397. https:\/\/doi.org\/10.1016\/j.jocn.2016.02.002","journal-title":"J Clin Neurosci"},{"key":"3910_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/jmg.2005.036319","volume":"43","author":"DG Evans","year":"2006","unstructured":"Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME (2006) Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet 43:289\u2013294. https:\/\/doi.org\/10.1136\/jmg.2005.036319","journal-title":"J Med Genet"},{"key":"3910_CR42","doi-asserted-by":"publisher","unstructured":"Mallory GW, Pollock BE, Foote RL, Carlson ML, Driscoll CL, Link MJ (2014) Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes. Neurosurgery 74:292\u2013300; discussion 300\u2013291. https:\/\/doi.org\/10.1227\/neu.0000000000000264","DOI":"10.1227\/neu.0000000000000264"},{"key":"3910_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-020-03423-w","author":"L Soderlund Diaz","year":"2020","unstructured":"Soderlund Diaz L, Hallqvist A (2020) LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-020-03423-w","journal-title":"J Neurooncol"},{"key":"3910_CR44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s10147-018-1267-6","volume":"23","author":"Z Chen","year":"2018","unstructured":"Chen Z, Takehana K, Mizowaki T, Uto M, Ogura K, Sakanaka K, Arakawa Y, Mineharu Y, Miyabe Y, Mukumoto N, Miyamoto S, Hiraoka M (2018) Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation. Int J Clin Oncol 23:608\u2013614. https:\/\/doi.org\/10.1007\/s10147-018-1267-6","journal-title":"Int J Clin Oncol"},{"key":"3910_CR45","doi-asserted-by":"crossref","unstructured":"Tosi U, Lavieri MET, An A, Maayan O, Guadix SW, DeRosa AP, Christos PJ, Pannullo S, Stieg PE, Brandmaier A, Knisely JPS, Ramakrishna R (2021) Outcomes of stereotactic radiosurgery for large vestibular schwannomas: a systematic review and meta-analysis. Neuro-Oncol Pract Online Before Print","DOI":"10.1007\/s11060-021-03910-8"},{"issue":"Suppl","key":"3910_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3171\/2010.8.Gks10954","volume":"113","author":"WY Chung","year":"2010","unstructured":"Chung WY, Pan DH, Lee CC, Wu HM, Liu KD, Yen YS, Guo WY, Shiau CY, Shih YH (2010) Large vestibular schwannomas treated by Gamma Knife surgery: long-term outcomes. J Neurosurg 113(Suppl):112\u2013121. https:\/\/doi.org\/10.3171\/2010.8.Gks10954","journal-title":"J Neurosurg"},{"key":"3910_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10143-016-0728-5","volume":"39","author":"BS Kim","year":"2016","unstructured":"Kim BS, Seol HJ, Lee JI, Shin HJ, Park K, Kong DS, Nam DH, Cho YS (2016) Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges. Neurosurg Rev 39:643\u2013653. https:\/\/doi.org\/10.1007\/s10143-016-0728-5","journal-title":"Neurosurg Rev"},{"key":"3910_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3171\/2016.9.Jns161463","volume":"128","author":"IJ Kruyt","year":"2018","unstructured":"Kruyt IJ, Verheul JB, Hanssens PEJ, Kunst HPM (2018) Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas. J Neurosurg 128:49\u201359. https:\/\/doi.org\/10.3171\/2016.9.Jns161463","journal-title":"J Neurosurg"},{"key":"3910_CR49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jocn.2007.07.078","volume":"15","author":"YH Kuo","year":"2008","unstructured":"Kuo YH, Roos D, Brophy BP (2008) Linear accelerator radiosurgery for treatment of vestibular schwannomas in neurofibromatosis 2. J Clin Neurosci 15:744\u2013748. https:\/\/doi.org\/10.1016\/j.jocn.2007.07.078","journal-title":"J Clin Neurosci"},{"key":"3910_CR50","first-page":"29","volume":"9","author":"N Massager","year":"2013","unstructured":"Massager N, Delbrouck C, Masudi J, De Smedt F, Devriendt D (2013) Hearing preservation and tumour control after radiosurgery for NF2-related vestibular schwannomas. B-ENT 9:29\u201336","journal-title":"B-ENT"},{"key":"3910_CR51","doi-asserted-by":"publisher","unstructured":"Mathieu D, Kondziolka D, Flickinger JC, Niranjan A, Williamson R, Martin JJ, Lunsford LD (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60: 460\u2013468; discussion 468\u2013470 https:\/\/doi.org\/10.1227\/01.Neu.0000255340.26027.53","DOI":"10.1227\/01.Neu.0000255340.26027.53"},{"key":"3910_CR52","doi-asserted-by":"publisher","unstructured":"Meijer OW, Vandertop WP, Lagerwaard FJ, Slotman BJ (2008) Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2. Neurosurgery 62: A37\u201342; discussion A42\u201333 https:\/\/doi.org\/10.1227\/01.neu.0000325935.23852.9d","DOI":"10.1227\/01.neu.0000325935.23852.9d"},{"key":"3910_CR53","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/cncr.24036","volume":"115","author":"JH Phi","year":"2009","unstructured":"Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW (2009) Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation. Cancer 115:390\u2013398. https:\/\/doi.org\/10.1002\/cncr.24036","journal-title":"Cancer"},{"key":"3910_CR54","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/jnnp.74.9.1288","volume":"74","author":"JG Rowe","year":"2003","unstructured":"Rowe JG, Radatz MW, Walton L, Soanes T, Rodgers J, Kemeny AA (2003) Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis. J Neurol Neurosurg Psychiatry 74:1288\u20131293. https:\/\/doi.org\/10.1136\/jnnp.74.9.1288","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3910_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11060-010-0181-1","volume":"98","author":"MS Sharma","year":"2010","unstructured":"Sharma MS, Singh R, Kale SS, Agrawal D, Sharma BS, Mahapatra AK (2010) Tumor control and hearing preservation after Gamma Knife radiosurgery for vestibular schwannomas in neurofibromatosis type 2. J Neurooncol 98:265\u2013270. https:\/\/doi.org\/10.1007\/s11060-010-0181-1","journal-title":"J Neurooncol"},{"key":"3910_CR56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neuchi.2016.03.005","volume":"64","author":"G Spatola","year":"2018","unstructured":"Spatola G, Carron R, Delsanti C, Thomassin JM, Roche PH, R\u00e9gis J (2018) Long-term results of Gamma-knife stereotactic radiosurgery for vestibular schwannomas in patients with type 2 neurofibromatosis. Neurochirurgie 64:355\u2013363. https:\/\/doi.org\/10.1016\/j.neuchi.2016.03.005","journal-title":"Neurochirurgie"},{"key":"3910_CR57","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3171\/jns.1999.90.5.0815","volume":"90","author":"BR Subach","year":"1999","unstructured":"Subach BR, Kondziolka D, Lunsford LD, Bissonette DJ, Flickinger JC, Maitz AH (1999) Stereotactic radiosurgery in the management of acoustic neuromas associated with neurofibromatosis Type 2. J Neurosurg 90:815\u2013822. https:\/\/doi.org\/10.3171\/jns.1999.90.5.0815","journal-title":"J Neurosurg"},{"issue":"Suppl","key":"3910_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3171\/2014.8.Gks141503","volume":"121","author":"S Sun","year":"2014","unstructured":"Sun S, Liu A (2014) Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2. J Neurosurg 121(Suppl):143\u2013149. https:\/\/doi.org\/10.3171\/2014.8.Gks141503","journal-title":"J Neurosurg"},{"key":"3910_CR59","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000107359","volume":"85","author":"JA Vachhani","year":"2007","unstructured":"Vachhani JA, Friedman WA (2007) Radiosurgery in patients with bilateral vestibular schwannomas. Stereotact Funct Neurosurg 85:273\u2013278. https:\/\/doi.org\/10.1159\/000107359","journal-title":"Stereotact Funct Neurosurg"},{"key":"3910_CR60","doi-asserted-by":"publisher","unstructured":"Kida Y, Kobayashi T, Tanaka T, Mori Y (2000) Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 53: 383\u2013389; discussion 389\u2013390. https:\/\/doi.org\/10.1016\/s0090-3019(00)00174-9","DOI":"10.1016\/s0090-3019(00)00174-9"},{"key":"3910_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046132","volume":"7","author":"AR Asthagiri","year":"2012","unstructured":"Asthagiri AR, Vasquez RA, Butman JA, Wu T, Morgan K, Brewer CC, King K, Zalewski C, Kim HJ, Lonser RR (2012) Mechanisms of hearing loss in neurofibromatosis type 2. PLoS ONE 7:e46132. https:\/\/doi.org\/10.1371\/journal.pone.0046132","journal-title":"PLoS ONE"},{"key":"3910_CR62","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/mao.0000000000002984","volume":"42","author":"K Goshtasbi","year":"2021","unstructured":"Goshtasbi K, Abouzari M, Yasaka TM, Soltanzadeh-Zarandi S, Sarna B, Lin HW, Djalilian HR (2021) Treatment analysis and overall survival outcomes of patients with bilateral vestibular schwannoma. Otol Neurotol 42:592\u2013597. https:\/\/doi.org\/10.1097\/mao.0000000000002984","journal-title":"Otol Neurotol"},{"key":"3910_CR63","doi-asserted-by":"publisher","unstructured":"Peyre M, Goutagny S, Bah A, Bernardeschi D, Larroque B, Sterkers O, Kalamarides M (2013) Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results. Neurosurgery 72: 907\u2013913; discussion 914; quiz 914. https:\/\/doi.org\/10.1227\/NEU.0b013e31828bae28","DOI":"10.1227\/NEU.0b013e31828bae28"},{"key":"3910_CR64","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1007\/s00405-014-3317-7","volume":"272","author":"G Kontorinis","year":"2015","unstructured":"Kontorinis G, Nichani J, Freeman SR, Rutherford SA, Mills S, King AT, Mawman D, Huson S, O\u2019Driscoll M, Gareth Evans D, Lloyd SK (2015) Progress of hearing loss in neurofibromatosis type 2: implications for future management. Eur Arch Otorhinolaryngol 272:3143\u20133150. https:\/\/doi.org\/10.1007\/s00405-014-3317-7","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3910_CR65","doi-asserted-by":"publisher","unstructured":"Harris GJ, Plotkin SR, Maccollin M, Bhat S, Urban T, Lev MH, Slattery WH (2008) Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II. Neurosurgery 62:1314\u20131319; discussion 1319\u20131320. https:\/\/doi.org\/10.1227\/01.neu.0000333303.79931.83","DOI":"10.1227\/01.neu.0000333303.79931.83"},{"key":"3910_CR66","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","volume":"54","author":"D Halliday","year":"2017","unstructured":"Halliday D, Emmanouil B, Pretorius P, MacKeith S, Painter S, Tomkins H, Evans DG, Parry A (2017) Genetic severity score predicts clinical phenotype in NF2. J Med Genet 54:657\u2013664. https:\/\/doi.org\/10.1136\/jmedgenet-2017-104519","journal-title":"J Med Genet"},{"key":"3910_CR67","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/jmg.35.6.450","volume":"35","author":"DG Evans","year":"1998","unstructured":"Evans DG, Trueman L, Wallace A, Collins S, Strachan T (1998) Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 35:450\u2013455. https:\/\/doi.org\/10.1136\/jmg.35.6.450","journal-title":"J Med Genet"},{"key":"3910_CR68","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-019-02029-5","volume":"139","author":"S Coy","year":"2020","unstructured":"Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S (2020) An update on the CNS manifestations of neurofibromatosis type 2. Acta Neuropathol 139:643\u2013665. https:\/\/doi.org\/10.1007\/s00401-019-02029-5","journal-title":"Acta Neuropathol"},{"key":"3910_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/0883073816666736","volume":"32","author":"S Ardern-Holmes","year":"2017","unstructured":"Ardern-Holmes S, Fisher G, North K (2017) Neurofibromatosis type 2. J Child Neurol 32:9\u201322. https:\/\/doi.org\/10.1177\/0883073816666736","journal-title":"J Child Neurol"},{"key":"3910_CR70","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1054\/bjoc.1999.1030","volume":"82","author":"ME Baser","year":"2000","unstructured":"Baser ME, Evans DG, Jackler RK, Sujansky E, Rubenstein A (2000) Neurofibromatosis 2, radiosurgery and malignant nervous system tumours. Br J Cancer 82:998. https:\/\/doi.org\/10.1054\/bjoc.1999.1030","journal-title":"Br J Cancer"},{"key":"3910_CR71","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/nejm198810203191601","volume":"319","author":"E Ron","year":"1988","unstructured":"Ron E, Modan B, Boice JD Jr, Alfandary E, Stovall M, Chetrit A, Katz L (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033\u20131039. https:\/\/doi.org\/10.1056\/nejm198810203191601","journal-title":"N Engl J Med"},{"key":"3910_CR72","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/mao.0000000000000272","volume":"35","author":"A Maniakas","year":"2014","unstructured":"Maniakas A, Saliba I (2014) Neurofibromatosis type 2 vestibular schwannoma treatment: a review of the literature, trends, and outcomes. Otol Neurotol 35:889\u2013894. https:\/\/doi.org\/10.1097\/mao.0000000000000272","journal-title":"Otol Neurotol"},{"key":"3910_CR73","doi-asserted-by":"publisher","DOI":"10.3171\/2016.11.Jns16498","author":"H Nakatomi","year":"2017","unstructured":"Nakatomi H, Jacob JT, Carlson ML, Tanaka S, Tanaka M, Saito N, Lohse CM, Driscoll CLW, Link MJ (2017) Long-term risk of recurrence and regrowth after gross-total and subtotal resection of sporadic vestibular schwannoma. J Neurosurg. https:\/\/doi.org\/10.3171\/2016.11.Jns16498","journal-title":"J Neurosurg"},{"key":"3910_CR74","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/MAO.0b013e318248eaaa","volume":"33","author":"JR Tysome","year":"2012","unstructured":"Tysome JR, Macfarlane R, Durie-Gair J, Donnelly N, Mannion R, Knight R, Harris F, Vanat ZH, Tam YC, Burton K, Hensiek A, Raymond FL, Moffat DA, Axon PR (2012) Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2. Otol Neurotol 33:466\u2013472. https:\/\/doi.org\/10.1097\/MAO.0b013e318248eaaa","journal-title":"Otol Neurotol"},{"key":"3910_CR75","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.otc.2018.07.015","volume":"51","author":"V Kaul","year":"2018","unstructured":"Kaul V, Cosetti MK (2018) Management of vestibular schwannoma (Including NF2): facial nerve considerations. Otolaryngol Clin North Am 51:1193\u20131212. https:\/\/doi.org\/10.1016\/j.otc.2018.07.015","journal-title":"Otolaryngol Clin North Am"},{"key":"3910_CR76","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2017.12.Focus17669","volume":"44","author":"D Starnoni","year":"2018","unstructured":"Starnoni D, Daniel RT, Tuleasca C, George M, Levivier M, Messerer M (2018) Systematic review and meta-analysis of the technique of subtotal resection and stereotactic radiosurgery for large vestibular schwannomas: a \u201cnerve-centered\u201d approach. Neurosurg Focus 44:E4. https:\/\/doi.org\/10.3171\/2017.12.Focus17669","journal-title":"Neurosurg Focus"},{"key":"3910_CR77","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11060-013-1282-4","volume":"116","author":"BM Anderson","year":"2014","unstructured":"Anderson BM, Khuntia D, Bentzen SM, Geye HM, Hayes LL, Kuo JS, Baskaya MK, Badie B, Basavatia A, Pyle GM, Tom\u00e9 WA, Mehta MP (2014) Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery. J Neurooncol 116:187\u2013193. https:\/\/doi.org\/10.1007\/s11060-013-1282-4","journal-title":"J Neurooncol"},{"key":"3910_CR78","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1700\/1491.16411","volume":"100","author":"J Wagner","year":"2014","unstructured":"Wagner J, Welzel T, Habermehl D, Debus J, Combs SE (2014) Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature. Tumori 100:189\u2013194. https:\/\/doi.org\/10.1700\/1491.16411","journal-title":"Tumori"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03910-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03910-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03910-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T08:16:06Z","timestamp":1643962566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03910-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3910"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03910-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interest, financial or otherwise, to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}